YK11 YK-11 CAS: 431579-34-9

CAS NO: 431579-34-9
YK11 YK-11
Chemical Name: YK11/YK-11
Molecular Formula: C25H34O6
Formula Weight: 430.53 g/mol
CAS No: 431579-34-9
Description Review
Description

YK11 is a synthetic steroid that is known for its ability to increase muscle mass and enhance athletic performance. Unlike other steroids, YK11 is classified as a selective androgen receptor modulator (SARM), meaning it selectively binds to androgen receptors in the muscles, leading to increased protein synthesis and enhanced muscle growth.

Top Searched Keywords on Google and Synonyms on google:

YK11 Myostatin inhibitor Selective androgen receptor modulator

Health Benefits:

YK11 has been found to have several health benefits, including increased muscle mass and strength, improved bone density, and enhanced athletic performance. Additionally, it has been found to improve overall well-being, increase energy levels, and decrease the risk of serious medical conditions such as osteoporosis and muscle wasting.

Potential Effects:

YK11 is known to have potent muscle-building effects, making it a popular choice among athletes and bodybuilders. It has been shown to increase muscle mass and strength, while also enhancing athletic performance and endurance. Additionally, it has been found to improve bone density and reduce the risk of osteoporosis.

Mechanisms:

YK11 works by selectively binding to androgen receptors in the muscles, leading to increased protein synthesis and enhanced muscle growth. Additionally, it acts as a myostatin inhibitor, which is a protein that limits muscle growth in the body. By inhibiting myostatin, YK11 can further enhance muscle growth and improve athletic performance.

Safety:

While YK11 has been found to be generally safe, there are some potential side effects that should be considered before use. These include an increase in acne, hair growth, and changes in libido. Additionally, it may affect liver and kidney function, and as such, it should only be used under the guidance of a qualified medical professional.

Side-Effects:

Some potential side effects associated with YK11 include an increase in acne, hair growth, and changes in libido. Additionally, it may affect liver and kidney function.

Dosage Information:

The recommended dosage of YK11 varies depending on the intended use. However, for muscle-building purposes, a dosage of 10-20mg per day is typically recommended. These dosages should only be used under the guidance of a qualified medical professional to ensure maximum safety and effectiveness.

In conclusion, YK11 is a potent and effective selective androgen receptor modulator that has been found to have several health benefits, including increased muscle mass and strength, improved bone density, and enhanced athletic performance. While it is generally safe, potential side effects should be considered before use, and it should only be used under the guidance of a qualified medical professional.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code
Message Us